Jun 19, 8:51 p.m.
Create my watchlists and portfolios login | register
zoom
Frankfurt: ACOR.FSE at 06/19, 06/20/13 ET - show other symbols

Acorda Therapeutics Inc.

€ 26.38 +1.08 (+4.25%)

advertisement

Acorda Therapeutics upgraded to "outperform"

09/07/10 - Robert W. Baird

NEW YORK, September 7 (newratings.com) - Analysts at Robert W Baird upgrade Acorda Therapeutics Inc (ACOR) from "neutral" to "outperform." The target price is set to $40.



                                                                                                                        

Make newratings better! Is this site working for you?